Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;8(1):30-40.

Diagnosis and treatment of patients with thyroid cancer

Affiliations
Review

Diagnosis and treatment of patients with thyroid cancer

Quang T Nguyen et al. Am Health Drug Benefits. 2015 Feb.

Abstract

Background: Thyroid cancer is the most common malignancy of the endocrine system, representing 3.8% of all new cancer cases in the United States and is the ninth most common cancer overall. The American Cancer Society estimates that 62,450 people in the United States will be diagnosed with thyroid cancer in 2015, and 1950 deaths will result from the disease.

Objective: To review the current approach to the diagnosis and treatment of patients with thyroid cancer.

Discussion: Over the past 3 decades, there has been a dramatic increase in the number of people diagnosed with thyroid cancer, which may be attributable to the wide use of imaging studies, including ultrasounds, computed tomography, magnetic resonance imaging, and positron emission tomography scans that incidentally detect thyroid nodules. Thyroid cancer is divided into several main types, with papillary thyroid cancer being the most common. The treatment options for patients with thyroid cancer include the surgical removal of the entire thyroid gland (total thyroidectomy), radioactive iodine therapy, and molecular-targeted therapies with tyrosine kinase inhibitors. This article summarizes the diagnosis and treatment of thyroid cancer, with recommendations from the American Thyroid Association regarding thyroid nodules and differentiated thyroid cancer. Recently approved drugs and treatment trends are also explored.

Conclusion: The prognosis and treatment of thyroid cancer depend on the tumor type and its stage at the time of diagnosis. Many thyroid cancers remain stable, microscopic, and indolent. The increasing treatment options for patients with thyroid cancer, including therapies that were recently approved by the US Food and Drug Administration, have kept the mortality rate from this malignancy low, despite the increase in its incidence. Early diagnosis and appropriate treatment can improve prognosis and reduce mortality.

Keywords: endocrine system; fine-needle aspiration biopsy; radioactive iodine; thyroid cancer; thyroidectomy; tyrosine kinase inhibitors.

PubMed Disclaimer

Figures

None
Quang T. Nguyen

References

    1. National Cancer Institute. A snapshot of thyroid cancer. November 5, 2014. www.cancer.gov/researchandfunding/snapshots/thyroid. Accessed January 12, 2015.
    1. National Cancer Institute. SEER stat fact sheets: thyroid cancer. http://seer.cancer.gov/statfacts/html/thyro.html. Accessed January 12, 2015.
    1. American Cancer Society. Thyroid cancer: what are the key statistics about thyroid cancer? Revised January 12, 2015. www.cancer.org/cancer/thyroidcancer/detailedguide/thyroid-cancer-key-sta.... Accessed January 12, 2015.
    1. Knox MA. Thyroid nodules. Am Fam Physician. 2013; 88: 193–196. - PubMed
    1. Cooper DS, Doherty GM, Haugen BR, et al.for the American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2009; 19: 1167–1214. Errata in: Thyroid. 2010;20:674–675; Thyroid. 2010;20:942. - PubMed

LinkOut - more resources